Sanderling Venture Partners VI LP

CIK 1306717 · last filed 2024-11-05

Sanderling Venture Partners VI LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider bought $3.0M of SCPH on Nov 5, 2024. Across all open-market trades the lifetime net is −$128.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.7M across reported positions. The firm reports its address in San Mateo, CA. 12 SEC filings were submitted jointly with Pacira BioSciences, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$12.70M

Companies

2

Total Filings

4

Lifetime Open-Market Net

-$128.21M

Filer Profile

Reported Address

1300 S EL CAMINO REAL SUITE 203
SAN MATEO, CA 94402

Phone

(650) 401-2000

Related Filers

Pacira BioSciences, Inc. — 12 joint filings, latest 2013-04-15

Sanderling VI Beteiligungs GmbH & Co KG — 12 joint filings, latest 2024-11-05

Sanderling VI Limited Partnership — 12 joint filings, latest 2024-11-05

Sanderling Venture Partners VI Co Investment Fund LP — 12 joint filings, latest 2024-11-05

Sanderling Ventures Management VI — 11 joint filings, latest 2024-11-05

Sanderling Ventures VII, L.P. — 4 joint filings, latest 2024-11-05

Fred A Middleton — 3 joint filings, latest 2013-04-15

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP — 1 joint filings, latest 2013-04-15

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CalciMedica, Inc. (SCPH) Delisted	10%+ Owner	1,761,044	$5.67	$9.99M	$2.96M	1	2024-11-05
PCRX	Director	500,672	$25.36	$12.70M	-$131.17M	3	2013-03-20

Recent Filings

4 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-11-05	CalciMedica, Inc. (SCPH) Delisted	Buy (P)	+789,696	$2.96M	EDGAR
2013-03-20	PCRX	Mixed	−2,549,202	-$42.31M	EDGAR
2013-03-11	PCRX	Mixed	−1,181,920	-$38.89M	EDGAR
2013-01-25	PCRX	Mixed	−2,992,980	-$47.33M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.